FDA Approved Medical Products for:

Factor XIII deficiency

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Factor Xiii Concentrate (Human)
Trade Name
(Manufacturer Name)
Corifact
(CSL Behring L.L.C.)
Indication
The FDA has approved this product to be used in this manner.
For the routine prophylactic treatment of congenital factor XIII deficiency

Generic Name coagulation factor XIII A-subunit (recombinant)
Trade Name
(Manufacturer Name)
Tretten
(Novo Nordisk, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Routine prophylaxis of bleeding in patients with congenital Factor XIII A-subunit deficiency.
More Information about this product Drug Information Portal